# The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis

> **NCT03073798** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 12 (actual)

## Conditions studied

- COPD
- Chronic Bronchitis
- Emphysema

## Interventions

- **DRUG:** Roflumilast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03073798
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-18
- **Primary completion:** 2015-05-14
- **Final completion:** 2015-05-14
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03073798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03073798, "The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03073798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*